These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14705756)

  • 1. Stroke: strategies for primary prevention.
    Ezekowitz JA; Straus SE; Majumdar SR; McAlister FA
    Am Fam Physician; 2003 Dec; 68(12):2379-86. PubMed ID: 14705756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke prevention in diabetes and obesity.
    Kurukulasuriya LR; Govindarajan G; Sowers J
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):487-502. PubMed ID: 16918267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
    Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
    J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary and secondary prevention of ischemic stroke].
    Awada A
    J Med Liban; 2011; 59(4):213-9. PubMed ID: 22746010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke.
    Arima H
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):627-36. PubMed ID: 19505278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in stroke: prevention, protection and recovery.
    Switzer JA; Hess DC
    Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stroke--risk factors and primary prevention].
    Asplund K
    Lakartidningen; 2003 Oct; 100(44):3500-5. PubMed ID: 14651008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for the prevention of stroke.
    Dahlöf B
    J Hypertens Suppl; 2006 Apr; 24(2):S3-9. PubMed ID: 16601558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient ischemic attacks: Part II. Treatment.
    Solenski NJ
    Am Fam Physician; 2004 Apr; 69(7):1681-8. PubMed ID: 15086040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke prevention, blood cholesterol and statins.
    Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
    Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of cerebral ischemic vascular accidents].
    Jaillard A; Besson G; Hommel M
    Rev Prat; 1998 Jan; 48(2):165-70. PubMed ID: 9781228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
    Moonis M; Fisher M
    Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW; Badellino KO
    J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
    Piechowski-Jóźwiak B; Bogousslavsky J
    Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.